News - Global, Vaccines

Filter

Current filters:

GlobalVaccines

Popular Filters

Sanofi Pasteur wins order for IPV from UNICEF, cutting price to $1 per dose

28-02-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, says that UNICEF, the organization…

GlobalMarkets & MarketingPharmaceuticalPricingSanofiSanofi PasteurVaccines

MSF calls for urgent action on vaccines to save lives

MSF calls for urgent action on vaccines to save lives

29-10-2013

Humanitarian medical organization Medecins Sans Frontieres is calling for four key policy changes to…

GlobalHealthcarePharmaceuticalPoliticsPricingVaccines

H1N1 virus market to be worth $273 million by 2018

22-10-2013

The H1N1 vaccines market has been forecast to decline in value over the next five years, reaching a value…

BiotechnologyFinancialGlobalHealthcareVaccines

Newly accessible Japanese encephalitis vaccine will make saving children easier in developing countries

09-10-2013

A newly accessible vaccine against Japanese encephalitis which will make the protection of more children…

China National BiotecGlobalPharmaceuticalRegulationVaccines

GAVI Alliance gets reduced price offers from Pfizer and GSK

30-07-2013

The price that the GAVI Alliance, a public/private partnership, pays for lifesaving pneumococcal vaccines…

GlaxoSmithKlineGlobalPfizerPharmaceuticalPricingVaccines

Infectious disease treatments market driven by growth in middle-income to low-income countries

17-05-2013

The infectious disease treatments market increased at a compound annual growth rate (CAGR) of 6.9% between…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalVaccines

More collaboration needed to raise vaccination rates in developing nations, says analyst

12-04-2013

More collaboration is needed between pharmaceuticals companies, public health organizations and governments…

GlobalHealthcarePharmaceuticalResearchVaccines

H1N1 pandemic fears to maintain lofty US flu vaccination levels, says GlobalData

08-01-2013

US demand for influenza vaccines will remain high in the coming decade, following a post-flu pandemic…

Anti-viralsGlobalMarkets & MarketingNorth AmericaPharmaceuticalVaccines

Further initiatives from GlaxoSmithKline to help tackle global health challenges; TB deal with Aeras

12-10-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday announced new measures to further advance its commitment…

Antibiotics and Infectious diseasesGlaxoSmithKlineGlobalHealthcarePharmaceuticalResearchVaccines

New Global Vaccine Action Plan does not go far enough, says MSF

18-05-2012

A new, 10-year, multi-billion dollar action plan for global vaccination may fail to deliver if it does…

GlobalHealthcarePharmaceuticalVaccines

New global data on influenza vaccine provision and level of support for immunization policies

28-11-2011

The findings of two studies being published this week in peer-reviewed journals look at global vaccination…

GlobalHealthcarePharmaceuticalRespiratory and PulmonaryVaccines

Cancer vaccines market set to see change, will grow to over $9 billion by 2018

24-10-2011

The global cancer vaccines market in seven key markets (the USA, France, Germany, Italy, Spain, UK and…

CervarixDendreonGardasilGlaxoSmithKlineGlobalMarkets & MarketingMerck & CoOncologyPharmaceuticalProvengeVaccines

Global vaccines market to be worth $20.8 billion in 2015, says Visiongain

11-10-2011

The worldwide vaccines market will reach a value of $20.8 billion in 2015, nearly double the $10.7 billion…

GlobalMarkets & MarketingPharmaceuticalVaccines

GAVI Alliance delivers on its promise to tackle diarrhea and pneumonia

29-09-2011

The GAVI Alliance announced this week that it will provide funding for 16 more developing countries to…

GlobalHealthcarePharmaceuticalVaccines

Public views over influenza driving growth in vaccine market, set to reach $52 billion by 2016

14-09-2011

In 2007 the world vaccine market was worth nearly $24.5 billion and is forecast to achieve a valuation…

GlobalMarkets & MarketingPharmaceuticalVaccines

Back to top